NetworkNewsBreaks Archive - Page 1998 of 2081

ThursdayApr 27, 2017 12:57 pm

NetworkNewsBreaks – Medigus Ltd.’s (NASDAQ: MDGS) MUSE™ System for GERD Used in First 10 Patients in CFDA’s Clinical Study

Medigus (NASDAQ: MDGS) this morning said that the first 10 procedures have been performed as the initial phase of the China Food and Drug Administration (CFDA) multi-center MUSE™ clinical study. The procedures for the clinical study, which will include roughly 62 patients, have started at four hospitals in China and are expected to continue through 2017. Data from the trial is anticipated to be reported to the CFDA in 2018 as part of the company’s submission for approval to sell MUSE™ in China. “We are looking forward to a successful clinical trial in China, which will lead to higher adoption…

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Unique Strategy Aims to Remove Risk While Expanding Portfolio

SinglePoint (OTC: SING) continues to pursue strategic opportunities to widen its foothold in the cannabis industry while hedging itself against potential risks regarding the legality of marijuana. “Focused on innovation, SinglePoint is expanding its portfolio in the cannabis markets with the strategic acquisition of companies that profit from the cannabis industry but don’t touch the plant itself. There’s little doubt that the marijuana market in the United States will continue to flourish and is poised for explosive upside growth. SinglePoint’s strategy positions the company to maximize profit from the marijuana markets yet virtually eliminate any downside risk exposure. The company’s…

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) Reiterated with ‘Buy’ Rating, $11 PT at Aegis Capital

Aegis Capital has reiterated a ‘Buy’ rating and a price target of $11 on Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) following the company’s recent presentation at the 2017 European Association for the Study of the Liver (EASL). The company presented two posters supporting further development of emricasan, showing that a reduction in MELD scores lowers risk of liver transplantation or death compared to patients with stable or increased MELD scores. The analyst noted that the posters signify that the continued development of emricasan is warranted. For more information, visit www.conatuspharma.com About Conatus Pharmaceuticals Conatus is a biotechnology company focused on the development…

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Generates E-Commerce Through Social Media Marketing

An April 2016 report by McKinsey & Company, Consumer China 2016 Survey (http://nnw.fm/QHb20), suggests that social media is gaining importance for companies like Moxian (NASDAQ: MOXC). “Moxian, Inc. is committed to growth in China’s online-to-offline (O2O) retail market, which is predicted by the Chinese to reach $48 billion in 1H17. Social media, an important part of Moxian’s marketing strategy, is playing a growing role in generating e-commerce apparel and dining revenues, research shows. A report by McKinsey & Company finds that the online market is changing retail buying patterns within China. Moxian is a high technology company which is transitioning…

ThursdayApr 27, 2017 12:12 pm

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $41 PT on Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR)

Aegis Capital Corp. has reiterated a ‘Buy’ rating and $41 price target on the stock of Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR). The report follows the company’s recent presentation of encouraging data for eptinezumab (formerly ALD403) at the 69th Annual American Academy of Neurology (AAN) meeting. Eptinezumab is currently in phase 3 clinical development for the prevention of chronic migraines. The Aegis analyst noted that this data suggests that increases in responder rates and reductions in HIT-6 scores for eptinezumab resulted in improved quality of life for those with chronic migraines. Additional data is expected to be released in the second…

ThursdayApr 27, 2017 11:49 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Successfully Collects Data from 500 Surgeries

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced that, via its ORHub platform, the company has successfully collected data from 500 surgeries. “ORHub's achievement of recording more than 500 surgical cases is a clear message that our software is performing as expected and becoming a fixture in the operating room,” Wesley Mitchell, chief technology officer for ORHub, stated in the news release. “We have been the system of record for several months without issue at two major medical institutions and will be announcing additional provider participation shortly. The data we have collected is providing valuable insight that is…

WednesdayApr 26, 2017 1:34 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 26, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ORRP 25.00% – News: Hosts corporate update conference call LLEX 14.00% – News: Secures new financing of $140M; receives approval to list on NYSE CETV 11.64% – News: Posts Q1 2017 financial results RTK 9.20% – News: Holding conference call to discuss Q1 2017 results on May 11 TROV 8.03% – News: Releasing Q1 2017 financial results, hosting conference call on May 10 SFIV 7.14% – News: Plans to issue forward stock split/dividend FLKS…

WednesdayApr 26, 2017 12:03 pm

NetworkNewsBreaks – Lightwave Logic, Inc. (LWLG) Achieves Bandwidth Suitable for 25Gbps in Modulator Prototype

Shares of Lightwave Logic (OTCQB: LWLG) are up 5% in mid-day trade following the company’s news that it has achieved bandwidth suitable for 25Gbps data rates in an all-organic polymer ridge waveguide intensity modulator prototype, representing a significant improvement over its initial 10Gbps device modulator. The Mach-Zehnder design allows Lightwave to address 100Gbps using its polymer photonics integrated circuit technology platform. "We expect that the 25Gbps device will generate significant industry attention as we squarely address powerful, cost-effective miniaturized solutions for both today's 100Gbps, and future 400Gbps higher performance markets," Lightwave CEO Tom Zelibor stated in the news release. To…

WednesdayApr 26, 2017 12:01 pm

NetworkNewsBreaks – Finjan Holdings, Inc.’s (NASDAQ: FNJN) Finjan Mobile Subsidiary Partners with Avira to Extend Market Reach

Finjan Holdings (NASDAQ: FNJN) this morning said its Finjan Mobile subsidiary has entered into a partnership agreement with Avira, Inc. through which Avira will provide its Virtual Private Network (VPN) Platform for distribution and sale by Finjan Mobile as part of its VitalSecurity™ suite of product offerings. Additionally, the companies entered into a confidential cross-license under their respective patents. "As we work to build upon our suite of secured products, the partnership with Avira will allow us to reach a much broader customer base across multiple platforms. We are committed to offering a best-in-class suite of secure mobile applications and…

WednesdayApr 26, 2017 11:19 am

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Targets $17B Tankless Water Heater Industry

Bollente Companies (OTC: BOLC), through its trutankless division, is strengthening its lead in the tankless water heater industry with an award-winning, energy saving solution that addresses a multi-billion dollar demand. “Globally, tankless water heater sales generated an estimated revenue of nearly $17 billion, according to Persistence Market Research (http://nnw.fm/83kBA), and they are projected to exceed well over $25 billion by 2024. This market segment represents just a small part of the global green building sector, which is currently outpacing overall U.S. construction growth and continues to double in size every three years. Smart appliances, including IoT devices in the home,…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks

NetworkNewsBreaks – Medigus Ltd.’s (NASDAQ: MDGS) MUSE™ System for GERD Used in First 10 Patients in CFDA’s Clinical Study

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Unique Strategy Aims to Remove Risk While Expanding Portfolio

NetworkNewsBreaks – Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) Reiterated with ‘Buy’ Rating, $11 PT at Aegis Capital

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Generates E-Commerce Through Social Media Marketing

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating, $41 PT on Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR)

NetworkNewsBreaks – ORHub, Inc. (ORHB) Successfully Collects Data from 500 Surgeries

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 26, 2017

NetworkNewsBreaks – Lightwave Logic, Inc. (LWLG) Achieves Bandwidth Suitable for 25Gbps in Modulator Prototype

NetworkNewsBreaks – Finjan Holdings, Inc.’s (NASDAQ: FNJN) Finjan Mobile Subsidiary Partners with Avira to Extend Market Reach

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Targets $17B Tankless Water Heater Industry

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search